113741-01-8

Basic information

• Product Name: 2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL
• Synonyms: [2-(2-METHYL-1H-IMIDAZOL-1-YL)ETHYL]AMINE DIHYDROCHLORIDE;2-(2-METHYLIMIDAZOLYL)ETHYLAMINE DIHYDROCHLORIDE;2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL;2-METHYL-1H-IMIDAZOLE-1-ETHYLAMINE;1-(2-Aminoethyl)-2-methyl-1H-imidazole;2-(2-Methyl-1H-imidazole-1-yl)ethylamine;2-(2-Methyl-1H-iMidazol-1-yl)ethanaMine hydrochloride;2-(2-Methyl-1H-iMidazol-1-yl)ethanaMine dihydrochloride
• CAS NO: 113741-01-8
• Molecular Formula: C6H13Cl2N3
• Molecular Weight: 198.09
• Product Categories: Building Blocks;Heterocyclic Building Blocks;Imidazoles
• Mol File: 113741-01-8.mol

Chemical Properties

• Melting Point: 116-120 °C
• Boiling Point: 273.598 °C at 760 mmHg
• Flash Point: 119.268 °C
• Appearance: /
• Density: 1.12 g/cm³
• Vapor Pressure: 0.00568mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: 2-8°C(protect from light)
• PKA: 9.42±0.10(Predicted)
• CAS DataBase Reference: 2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL(113741-01-8)
• EPA Substance Registry System: 2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL(113741-01-8)

Safety Data

• Hazard Codes: Xi
• Statements: 37/38-41
• Safety Statements: 26-39
• HazardClass: IRRITANT
• Hazardous Substances Data: 113741-01-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL is used as an intermediate compound for the synthesis of various pharmaceutical products. Its imidazole ring structure allows it to be a key component in the development of drugs targeting specific biological pathways.
Used in Agrochemical Industry:
2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL is used as a building block in the creation of agrochemicals, such as pesticides and herbicides. Its chemical properties enable it to be incorporated into molecules that can effectively control pests and weeds in agricultural settings.
Used in Dyes and Pigments Industry:
2-(2-METHYL-IMIDAZOL-1-YL)-ETHYLAMINE 2HCL is used as a colorant in the production of dyes and pigments. Its imidazole structure contributes to the color properties and stability of these products, making them suitable for various applications, such as textiles, plastics, and paints.

InChI:InChI=1/C6H11N3/c1-6-8-3-5-9(6)4-2-7/h3,5H,2,4,7H2,1H3

Upstream product

• 858512-76-2 2-[2-(2-methylimidazol-1-yl)ethyl]isoindole-1,3-dione 
• 693-98-1 2-methylimidazole 
• 689-98-5 chloroethylamine 
• 870-24-6 2-chloroethanamine hydrochloride 

Relevant articles and documents

(2-aminoethyl)-N hydrofluorination compd. manufacturing method

PROBLEM TO BE SOLVED: To provide a method for preparing an N-(2-aminoethyl)azole compound, which is a preparation method offering short reaction time, high purification efficiency of a final product, high production efficiency and high safety because a reaction solution undergoes no heat generation or rise of liquid level caused by bubbling. SOLUTION: The method for preparing the N-(2-aminoethyl)azole compound comprises reacting an azole-based compound (A) and an ethylamine derivative (B) having a leaving group at position 2 in the presence of a base (C) in a solvent (D) so as to prepare the N-(2-aminoethyl)azole compound. Here, the ethylamine derivative (B) having the leaving group at position 2 is fed to the reaction system in portions while the reaction system is maintained at 50-200°C. COPYRIGHT: (C)2010,JPOandINPIT

CINNAMIC ACID AMIDE DERIVATIVE

The present invention provides a cinnamic acid amide derivative having an excellent analgesic action. The cinnamic acid amide derivative of the present invention is a compound showing excellent analgesic actions to not only a nociceptive pain model animal but also a neuropathic pain model animal, which is very useful as an agent for treating various pain diseases showing acute or chronic pains or neuropathic pains.

Benzoxazole carboxamides for treating CINV and IBS-D

Compounds of formulae I and II: are disclosed as 5-HT3 inhibitors. Those compounds that exhibit central activity are useful in treating CINV; those that inhibit peripheral receptors are useful to treat IBS-D.